{"schema_version":"secwatch.filing_event.v1","accession":"0001600620-24-000087","form_type":"8-K","ticker":"AUPH","cik":"0001600620","company_name":"Aurinia Pharmaceuticals Inc.","filed_at":"2024-06-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.162812+00:00","generated_at":"2026-06-01T04:19:56.702635+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Aurinia shareholders reject say-on-pay, equity plan; four directors face conditional resignations","bullets":["CEO Peter Greenleaf and three other directors received less than majority support; conditional resignations submitted under Majority Voting Policy.","Say-on-pay vote failed: 30.8M for, 45.3M against, 0.5M abstain.","Equity Incentive Plan amendment not approved: 35.7M for, 40.5M against.","PricewaterhouseCoopers ratified as auditor with 85.6M for, 8.1M against.","Board will decide on the four directors' resignations within 90 days per policy."],"urls":{"canonical":"https://secwatch.observer/filing/0001600620-24-000087","json":"https://secwatch.observer/filing/0001600620-24-000087.json","markdown":"https://secwatch.observer/filing/0001600620-24-000087.md","text":"https://secwatch.observer/filing/0001600620-24-000087.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1600620/000160062024000087/0001600620-24-000087-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1600620/000160062024000087/auph-20240614.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:19:56.702635+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}